• Nenhum resultado encontrado

Blood vessel invasion as a strong independent prognostic indicator in non-small cell lung cancer: a systematic review and meta-analysis.

N/A
N/A
Protected

Academic year: 2017

Share "Blood vessel invasion as a strong independent prognostic indicator in non-small cell lung cancer: a systematic review and meta-analysis."

Copied!
8
0
0

Texto

Loading

Imagem

Table 1. Quality scores analysis of the 52 eligible studies by the European Lung Cancer Working Party score according to studies characteristics
Figure 1. Forest plot showing the combined relative hazard ratio for relapse-free survival in all patient populations by multivariate analysis.
Figure S1 The flow of the included studies.

Referências

Documentos relacionados

Survival and prognostic factors in patients with Non-Small Cell Lung Cancer treated in private health care.. Sobrevida e fatores prognósticos em pacientes com câncer de pulmão de

Lymph node isolated tumor cells and micrometastases in pathological stage I non-small cell lung cancer: prognostic significance. American Joint Committee

cancers are categorized as small cell lung cancer, a subtype with a neuroendocrine phenotype, or non-small cell lung cancer, which comprises adenocarcinoma, squamous cell

trial demonstrated that selenium supplementation may reduce risk of cancer including lung cancer among those with lower serum selenium ( , 106 ng/mL) [38], and a second study in

In a study cited by Antunes et al., on univariate analysis lymphatic, blood vessel and perinerual tumor invasion showed strong prognostic significance1. However, on

Pretreatment neutrophil count as an independent prognostic factor in advanced non-small- cell lung cancer: an analysis of Japan Multinational Trial Organisation LC00-03..

CONCLUSION: Serum albumin levels appear to be a significant independent prognostic factor for tumor recurrence in patients with stage I non-small cell lung cancer who have

Prognostic significance of metastases to mediastinal lymph node levels in resected non small cell lung carcinoma.. Surgery for stage IIIA-N2 non small cell